Earnings Call Summary | Ontrak(OTRK.US) Q1 2024 Earnings Conference
Earnings Call Summary | Ontrak(OTRK.US) Q1 2024 Earnings Conference
The following is a summary of the Ontrak, Inc. (OTRK) Q1 2024 Earnings Call Transcript:
以下是Ontrak, Inc.(OTRK)2024年第一季度财报电话会议记录摘要:
Financial Performance:
财务业绩:
Ontrak's Q1 2024 revenue was reported at $2.7 million, a 6% year over year increase, primarily fueled by a 15% increase in average enrolled members.
The average monthly disenrollment rate was 22%, marking an increase from 12% in Q1 2023, attributed to the non-renewal of a customer contract beyond Q1 2024.
The Q1 gross margin stood at 63.6%, slightly lower compared to Q1 2023's 66.5%. The company expects these levels to persist due to anticipated operational efficiency gains.
据报道,Ontrak的2024年第一季度收入为270万美元,同比增长6%,这主要是由平均注册会员增长15%推动的。
平均每月注销率为22%,较2023年第一季度的12%有所增加,这归因于2024年第一季度之后未续订客户合同。
第一季度的毛利率为63.6%,略低于2023年第一季度的66.5%。该公司预计,由于预期的运营效率提高,这些水平将持续下去。
Business Progress:
业务进展:
There has been approval for Ontrak to serve as a subcontractor for Community Care Plan, implying a 10% increase in the eligible members pool for the WholeHealth+ program.
The company is at the tail end of finalizing contracts with two major health plans, with planned pilot partnerships to follow post finalization.
The company reported enrolling 925 members and graduating 194 in Q1 2024.
Revenue for the following quarter is projected to lie between $2.4 million and $2.8 million.
Noteworthy feats include approval by Florida's Agency for Healthcare Administration for the commencement of implementation for the Community Care Plan, and the execution of several expansion contracts with Sentara Health.
Ontrak已获批准成为社区护理计划的分包商,这意味着Wholealth+计划的合格成员人数将增加10%。
该公司与两项主要健康计划的合同即将敲定,计划中的试点合作伙伴关系将在敲定后紧随其后。
该公司报告称,2024年第一季度注册了925名会员,194名成员毕业。
下一季度的收入预计在240万美元至280万美元之间。
值得注意的成就包括佛罗里达州医疗保健管理局批准开始实施社区护理计划,以及与Sentara Health签订了几份扩张合同。
More details: Ontrak IR
更多详情: Ontrak IR
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由 AI 生成。无法完全保证内容的准确性。欲了解更多详情,请访问投资者关系网站。本文仅供投资者参考,不构成任何投资建议。